Gian Paolo Caviglia Selected Research

Infections

12/2022	Possible Impact of Vitamin D Status and Supplementation on SARS-CoV-2 Infection Risk and COVID-19 Symptoms in a Cohort of Patients with Inflammatory Bowel Disease.
10/2022	A Review of HDV Infection.
11/2021	The hepatitis D virus in Italy. A vanishing infection, not yet a vanished disease.
1/2021	Incremental value of HBcrAg to classify 1582 HBeAg-negative individuals in chronic infection without liver disease or hepatitis.
4/2020	Analytical and clinical evaluation of a novel assay for anti-HBc IgG measurement in serum of subjects with overt and occult HBV infection.
11/2019	The medical impact of hepatitis D virus infection in Uzbekistan.
1/2019	Reply to: "Over-gap PCR amplification to identify presence of replication-competent HBV DNA from integrated HBV DNA: An updated occult HBV infection definition".
1/2018	Quantitation of HBV cccDNA in anti-HBc-positive liver donors by droplet digital PCR: A new tool to detect occult infection.
11/2016	Microscopic colitis in patients with mild duodenal damage: A new clinical and pathological entity ("lymphocytic enterocolitis")?
11/2014	Prediction of occult hepatitis B virus infection in liver transplant donors through hepatitis B virus blood markers.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gian Paolo Caviglia Research Topics

Disease

17	Fibrosis (Cirrhosis) 01/2024 - 11/2010
15	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 04/2024 - 11/2015
14	Non-alcoholic Fatty Liver Disease 01/2024 - 01/2016
14	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 03/2016
11	Infections 12/2022 - 11/2012
10	Crohn Disease (Crohn's Disease) 01/2024 - 01/2015
10	Liver Diseases (Liver Disease) 01/2024 - 11/2010
8	Hepatitis B 11/2021 - 11/2012
6	Liver Cirrhosis (Hepatic Cirrhosis) 07/2023 - 01/2013
6	Insulin Resistance 11/2022 - 01/2016
6	Chronic Hepatitis B 07/2021 - 01/2017
5	Ulcerative Colitis 07/2023 - 03/2020
5	Inflammation (Inflammations) 05/2021 - 12/2014
5	Neoplasms (Cancer) 03/2021 - 01/2018
4	Hepatitis 01/2021 - 08/2014
4	Chronic Hepatitis C 10/2019 - 11/2012
3	Viremia 03/2022 - 09/2014
2	Celiac Disease (Celiac Sprue) 01/2023 - 11/2016
2	Superinfection 10/2022 - 11/2019
2	Hepatitis D 03/2022 - 11/2021
2	Liver Neoplasms (Liver Cancer) 01/2022 - 02/2021
2	Abdominal Pain (Pain, Abdominal) 10/2021 - 07/2020
2	Atrophy 07/2021 - 01/2021
2	Type 2 Diabetes Mellitus (MODY) 03/2021 - 10/2019
2	Dysbiosis 01/2021 - 10/2019
2	Colitis 01/2021 - 01/2020
2	Hemolytic Anemia 09/2014 - 10/2013
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2023
1	COVID-19 12/2022
1	Chronic Hepatitis D 10/2022
1	Epilepsy (Aura) 09/2022
1	Granuloma 08/2022
1	Portal Hypertension 08/2022
1	Periodontitis 05/2022
1	Hepatorenal Syndrome 01/2022
1	Ascites 01/2022
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 11/2021
1	Carcinogenesis 05/2021

Drug/Important Bio-Agent (IBA)

12	Biomarkers (Surrogate Marker)IBA 01/2023 - 12/2014
9	Antiviral Agents (Antivirals)IBA 01/2023 - 11/2010
9	Hepatitis B Surface Antigens (HBsAg)FDA Link 10/2022 - 11/2012
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2018
7	acarboxyprothrombin (PIVKA)IBA 01/2023 - 03/2016
7	AntigensIBA 11/2021 - 11/2012
6	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2022 - 03/2016
6	Adalimumab (Humira)FDA Link 11/2021 - 10/2019
6	Glucose (Dextrose)FDA LinkGeneric 03/2021 - 01/2015
6	DNA (Deoxyribonucleic Acid)IBA 04/2020 - 11/2012
5	vedolizumabIBA 04/2024 - 04/2019
5	Vitamin K FDA Link 01/2022 - 01/2018
4	CytokinesIBA 01/2023 - 05/2020
4	Insulin (Novolin)FDA Link 03/2021 - 01/2016
3	Vitamin D FDA LinkGeneric 01/2024 - 11/2021
3	Nonesterified Fatty Acids (NEFA)IBA 11/2022 - 11/2020
3	Interleukin-6 (Interleukin 6)IBA 05/2021 - 03/2020
3	zonulinIBA 01/2021 - 04/2019
3	InterferonsIBA 07/2017 - 11/2010
2	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2023 - 08/2022
2	Complement C3 (C3 Complement)IBA 01/2023 - 01/2022
2	Nicotinamide PhosphoribosyltransferaseIBA 01/2023 - 01/2020
2	Immunoglobulin G (IgG)IBA 12/2022 - 04/2020
2	AdiponectinIBA 11/2022 - 05/2021
2	RNA (Ribonucleic Acid)IBA 03/2022 - 09/2014
2	Monoclonal AntibodiesIBA 11/2021 - 05/2020
2	Biosimilar PharmaceuticalsIBA 07/2021 - 03/2020
2	GlypicansIBA 05/2021 - 10/2020
2	Circular DNAIBA 01/2021 - 01/2018
2	Ustekinumab (CNTO 1275)FDA Link 03/2020 - 04/2019
2	Azathioprine (Imuran)FDA LinkGeneric 11/2019 - 08/2019
2	Keratin-18 (Keratin 18)IBA 08/2015 - 01/2013
2	Ribavirin (Virazole)FDA LinkGeneric 09/2014 - 10/2013
1	Ferritins (Ferritin)IBA 01/2024
1	CarbohydratesIBA 11/2023
1	Phospholipases (Phospholipase)IBA 11/2023
1	Contrast MediaIBA 10/2023
1	CollagenIBA 01/2023
1	nicotinate phosphoribosyltransferaseIBA 01/2023
1	Small Untranslated RNAIBA 01/2023
1	LipidsIBA 11/2022
1	AdipokinesIBA 11/2022
1	Triglycerides (Triacylglycerol)IBA 11/2022
1	Indicators and Reagents (Reagents)IBA 11/2022
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 01/2022
1	Protein Isoforms (Isoforms)IBA 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2021
1	Volatile Fatty AcidsIBA 10/2021
1	Butyrates (Butyrate)IBA 10/2021
1	CalciumIBA 10/2021
1	PrebioticsIBA 10/2021
1	nasIBA 07/2021
1	AntralIBA 07/2021
1	LeptinIBA 05/2021

Therapy/Procedure

18	Therapeutics 04/2024 - 11/2010
2	Intravenous Administration 10/2023 - 07/2023
2	Mediterranean Diet 07/2023 - 07/2023
2	Gluten-Free Diet 01/2023 - 11/2016
2	Liver Transplantation 11/2021 - 11/2014
2	Biological Therapy 03/2020 - 04/2019
1	Vagus Nerve Stimulation 09/2022
1	Transjugular Intrahepatic Portasystemic Shunt 01/2022